Skip to content

Kiniksa Pharmaceuticals International

US · KNSA #1938 by market cap Listed 2018
93.90 +0.36 +0.38%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Kiniksa Pharmaceuticals International

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Founded
2024
CEO
Mr. Sanj K. Patel
Employees
366
Headquarters
London, Greater London, United Kingdom of Great Britain and Northern Ireland (the)
Fiscal year end
12-31
Website
kiniksa.com

Company profile

Exchange
US
Symbol
KNSA
Market-cap rank
#1938
Listing date
2018-05-24
Market cap
7.38B
Float cap
4.18B
Shares out
78.57M
Float shares
44.56M

Sectors & themes

Drug Manufacturers - Specialty & Generic Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.

Kiniksa Pharmaceuticals International discussion 0 comments

Add a comment